BioCryst Pharmaceuticals
BCRX
BCRX
241 hedge funds and large institutions have $1.42B invested in BioCryst Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 94 increasing their positions, 69 reducing their positions, and 24 closing their positions.
Holders
241
Holders Change
+11
Holders Change %
+4.78%
% of All Funds
3.86%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.13%
New
39
Increased
94
Reduced
69
Closed
24
Calls
$25.4M
Puts
$9.5M
Net Calls
+$15.9M
Net Calls Change
-$14.7M